skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:026653/0037   Pages: 5
Recorded: 07/26/2011
Attorney Dkt #:309122-102 MEDICURE
Conveyance: RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).
Total properties: 7
1
Patent #:
Issue Dt:
04/18/2000
Application #:
09061173
Filing Dt:
04/16/1998
Title:
TREATMENT OF IATROGENIC AND AGE-RELATED HYPERTENSION AND PHARMACEUTICAL COMPOSITIONS USEFUL THEREIN
2
Patent #:
Issue Dt:
03/28/2000
Application #:
09276280
Filing Dt:
03/25/1999
Title:
TREATMENT OF CARDIOVASCULAR AND RELATED PATHOLOGIES
3
Patent #:
Issue Dt:
12/03/2002
Application #:
09615201
Filing Dt:
07/13/2000
Title:
TREATMENT OF DIABETES AND RELATED PATHOLOGIES
4
Patent #:
NONE
Issue Dt:
Application #:
10215739
Filing Dt:
08/08/2002
Publication #:
Pub Dt:
01/09/2003
Title:
TREATMENT OF DIABETES AND RELATED PATHOLOGIES
5
Patent #:
NONE
Issue Dt:
Application #:
10551302
Filing Dt:
07/20/2006
Publication #:
Pub Dt:
02/08/2007
Title:
Modulation of cell death
6
Patent #:
NONE
Issue Dt:
Application #:
10551303
Filing Dt:
11/16/2006
Publication #:
Pub Dt:
07/19/2007
Title:
Compositions For Treating Angina
7
Patent #:
NONE
Issue Dt:
Application #:
10881864
Filing Dt:
06/30/2004
Publication #:
Pub Dt:
11/25/2004
Title:
Treatment of diabetes and related pathologies
Assignor
1
Exec Dt:
07/18/2011
Assignee
1
4-1200 WAVERLY STREET
WINNIPEG, CANADA R3T 0P4
Correspondence name and address
COOLEY LLP
101 CALIFORNIA STREET, 5TH FLOOR
SAN FRANCISCO, CA 94111

Search Results as of: 05/31/2024 11:52 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT